Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2022 / Oct / Quality Control and Jell-O
Quality assurance and quality control Regulation and standards Opinion and Personal Narratives

Quality Control and Jell-O

Laboratory QC is awaiting its renaissance – but what does that have to do with wobbly desserts?

By Daniel Johnson 10/17/2022 Opinion 3 min read

Share

Jell-O was initially patented in 1845 and gained popularity over the next 100 years, leading to major gelatin innovations. Around the 1960s, Jell-O (a registered trademark of Kraft Heinz), arguably met its peak of innovation – a point at which families enjoyed Jell-O molds filled with carrots, lettuce, and even tuna. So, how is this related to quality control (QC)? Because, in my view, QC is currently awaiting its own Jell-O renaissance.

The QC process has been static for decades and has rarely seen major laboratory innovations. After obtaining QC data, laboratory professionals often have different interpretations or don’t know how to use it to decide on next steps. So why even run QC if you can’t use the results? Perhaps you feel the need to satisfy guidelines or meet accreditation requirements – or perhaps it has simply become a habit.

One key area for QC improvement is troubleshooting. I have witnessed laboratories start troubleshooting QC by rerunning it, crossing their fingers for passing results so they can move on with their day – but troubleshooting QC problems is an art and takes time (which means that people often try to avoid it). My concern is that people fall into a “get it done” mentality, forgetting the true purpose of QC. QC is supposed to ensure that patients receive the right results – every time. Running QC material until it passes is neither “quality” nor “control.”

Another focus for improvement is to transition QC from a reactive to a proactive process. By nature, people are reactive to things over which they feel they have no control. To me, it makes no sense to wait for something to go wrong before we take measures to fix it – especially in healthcare. Current health trends include addressing problems, such as lack of access to healthy food, with the ultimate goal of preventing conditions, such as obesity and diabetes. We know that being proactive about health can prevent disease – so why not take the same approach to QC? A proactive approach saves time in the long run but, when labs have limited staff and resources, reactivity becomes the default. Often, either motivation or opportunity is lacking to bring in the innovations that would change this default – and this benefits no one.

We live in an age where our phones are mega-on-demand encyclopedias and our cars drive us – so it’s frustrating to see that many laboratories still manually input QC points into a spreadsheet. We have lakes – even oceans – of QC data on diagnostic devices; billions of QC data points are automatically created each year, but few are tapping into that power.

The future of QC still needs a roadmap – ideally one that would mean we never have to rerun QC. In this information age, we need to take advantage of all available data and think of sophisticated ways to add more sensors to devices so more data can be collected. These intelligent systems will foresee problems before they occur, self-heal, and calibrate without missing a beat. But a sea change like this requires a massive alignment of policies, people, and technology to set the stage. And so we wait for someone to come along and add some hot dogs to this “Jell-O,” changing the game forever. The first attempt may be for better or for worse – but, no matter the outcome, improvement can only begin with a willingness to try.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Daniel Johnson

Assistant Director, Marketing for Informatics and Quality Solutions, Sysmex America, Lincolnshire, Illinois, USA

More Articles by Daniel Johnson

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

R-Tracker: The First of Its Kind
Quality assurance and quality control
R-Tracker: The First of Its Kind

December 29, 2021

1 min read

Milestone is committed to enhancing patient safety with a new disruptive technology

The Big Freeze
Quality assurance and quality control
The Big Freeze

February 7, 2022

1 min read

Cryobioprinting could maximize the shelf life of bioprinted 3D tissues

Biospecimen Access For Biotechs
Quality assurance and quality control
Biospecimen Access For Biotechs

February 14, 2022

1 min read

Quality, provenance, and “taking pot luck”

Questions of Quality
Quality assurance and quality control
Questions of Quality

October 21, 2016

1 min read

The importance of quality is broadly accepted – witness the plethora of standards and guidelines – but do they lead to effective implementation?

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.